Delivery Order SPE2DB24D1021-SPE2DB25FEYGT
Award Date
7/7/25
Potential Completion Date
7/8/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,150.93 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 500S. The contract has an ultimate completion date of June 30, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,036.59, is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a completion date of May 20, 2025. The award is not set aside and involves open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order valued at $22,275.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication, with a performance period extending through May 20, 2025. The contract is noted as having no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a $16,028.49 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on December 3, 2024. The contract provides for the delivery of 4,566,590,738 units of CellCept 500 mg tablets by December 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor with no set-aside designation indicated. This contract award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of CELLCEPT 500 MG TABLET 500S. The contract has a ceiling value of $12,621.35 and is a Firm Fixed Price contract type. The Place of Performance is Conshohocken, PA. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop...
This federal contract award, valued at $1,203.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of May 14, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CELLCEPT 500 MG TABLET 100S. The contract has a firm fixed price of $8,112.06 and a completion date of June 17, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a firm fixed price of $6,014.65 and a performance period ending on July 7, 2025. The contract is not set aside and was awarded on July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,406.80, is for the delivery of CELLCEPT 500 MG TABLET 500S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a completion date of June 10, 2025. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. The company holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,177,785 units of the medication CellCept 500 mg tablet in 500-count containers. The contract has a firm fixed price of $33,780.80 and a performance period ending on May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...